Stock A017180 MYUNGMOON PHARM CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

News MYUNGMOON Pharm co.,Ltd

Equities

A017180

KR7017180001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
2,090 KRW -0.95% Intraday chart for MYUNGMOON Pharm co.,Ltd +2.20% -8.53%
Mar. 20 MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023.
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023.
CI
MYUNGMOON Pharm co.,Ltd's Equity Buyback announced on May 25, 2023, has expired with 278,592 shares, representing 0.82% for KRW 674.93 million.
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023.
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
MYUNGMOON Pharm co.,Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.
CI
MYUNGMOON Pharm co.,Ltd authorizes a Buyback Plan.
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
MYUNGMOON Pharm co.,Ltd(KOSE:A017180) dropped from S&P Global BMI Index
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
M2N Co.,Ltd cancelled the acquisition of an unknow stake in MYUNGMOON Pharm co.,Ltd.
CI
M2N Co.,Ltd agreed to acquire an unknow stake in MYUNGMOON Pharm co.,Ltd.
CI
Woo Seok-min agreed to acquire 2.4% stake in Myungmoon Investment Development Co. Ltd. from MYUNGMOON Pharm co.,Ltd for KRW 2.1 billion.
CI
Myungmoon Pharm. Co., LTD.(KOSE:A017180) added to S&P Global BMI Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A017180 Stock
  4. News MYUNGMOON Pharm co.,Ltd